Jump to: main navigation, sub navigation, service navigation, search, content.
The European Science Foundation recently concluded a foresight study on the topic of nanotechnology applied to medicine (Scientific Forward Look on Nanomedicine). The goal of this Forward Look was to exchange views on the current status of Nanomedicine between scientific experts and policy makers, and to reflect upon future developments, opportunities and challenges facing this important field in Europe and world wide. Over 100 international experts from academia, industry, private foundations and governmental agencies supporting scientific research have contributed to this activity.
The ESF Forward Look on Nanomedicine has led to a definition of the current status of the field and debates on strategic policy issues. An ESF Policy Briefing, which summarises recommendations from this Forward Look activity, is going to be published on 1 March 2005 (PDF). This policy paper provides only a brief summary of in-depth discussions throughout the foresight study. A full report documenting the detailed debate and analysis will be published separately.
Implementation of recommendations from the ESF Scientific Forward Look on Nanomedicine would strengthen Europe’s leading-edge research and ensure further development in Nanomedicine, resulting in reduced healthcare costs and the rapid realisation of medical benefits for all European citizens.
Contact
For more information about the ESF Forward Look on Nanomedicine and the conclusions please contact the following:
Mr. Jens Degett typo3/esf_contacts_form.php?unit=2&contact=88
For expert’s opinions, the following Members of the Steering Committee may be contacted
Professor Ruth Duncan
Center for Polymer Therapeutics
Welsh School of Pharmacy
United Kingdom
+44 (0)29 2087 4180
+44 (0)2920874536
typo3/esf_contacts_form.php?mail=99a64e47ea123994d56514493fd1a398
Expertise: Pharmaceutical and Clinical Applications of nanotechnology
Dr. Wolfgang Kreyling
GSF National Research Centre for Environment and Health
+49 89 3187 2309
+49 89 3187 3397
typo3/esf_contacts_form.php?mail=982dbf1ef3818720602843a85c894d6b
Expertise: Nanoparticles: applications and the toxicology.
Professor Hans Oberleithner
Institute of Physiology
University of Münster
+49 251 83 555 40
+49 251 83 55 331
typo3/esf_contacts_form.php?mail=c096d8e0a9632754d8a0ca5e1cda7410
Expertise: Nano Imaging at the Molecular Level
Dr. Alberto A. Gabizon
Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine
Jerusalem Israel
+972 2 655 5036
+972 2 652 1431
typo3/esf_contacts_form.php?mail=71c2050dedd07a632e4361cc6962edd2
Expertise: liposomes and nanomedicines in clinical use, especially in cancer treatment
Category: Media Centre, Press Releases 2005
Jump to: main navigation, sub navigation, service navigation, search, content.